Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. VTAK
stocks logo

VTAK

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
1.17M
+1118.75%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Catheter Precision, Inc. (VTAK) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -2.02%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-2.02%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Catheter Precision Inc (VTAK.A) is -0.20, compared to its 5-year average forward P/E of -0.29. For a more detailed relative valuation and DCF analysis to assess Catheter Precision Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-0.29
Current PE
-0.20
Overvalued PE
-0.02
Undervalued PE
-0.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.57
Current PS
0.00
Overvalued PS
1.07
Undervalued PS
0.07
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

VTAK News & Events

Events Timeline

(ET)
2025-12-03
08:10:00
Catheter Precision Secures Major Tender in Hungary
select
2025-12-01 (ET)
2025-12-01
08:20:00
Catheter Precision Launches LockeT Suture Retention Device in Switzerland
select
2025-11-25 (ET)
2025-11-25
08:05:31
Catheter Precision Reveals Inclusion of Important Ablation Procedures in ASC by CMS
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
12-01Globenewswire
Catheter Precision Launches LockeT Device in Switzerland with Positive Clinical Outcomes
  • Successful Product Launch: Catheter Precision has successfully launched its LockeT suture retention device in Switzerland, with the first clinical cases performed at Spitalzentrum Biel yielding excellent procedural outcomes and positive feedback from clinical and nursing teams, marking a significant technological advancement in the cardiac electrophysiology market.
  • Strategic Distribution Agreement: The partnership with FuMedica AG, a leading Swiss medical device distributor, enables rapid introduction of LockeT to hospitals and clinics across Switzerland, further expanding Catheter Precision's footprint in the European market.
  • Cost Efficiency Improvement: The intuitive design of the LockeT device not only reduces groin management costs but also supports same-day discharge, enhancing the overall patient experience and demonstrating its potential application in cardiac interventional procedures.
  • Global Market Expansion: With over 10,000 LockeTs shipped globally to date, Catheter Precision is actively expanding its business in the rapidly growing cardiac electrophysiology market, working diligently with partners to improve patient treatment outcomes.
[object Object]
Preview
9.5
11-14Newsfilter
Catheter Precision (VTAK) Announces Q3 and Year-to-Date Results for 2025

  • Financial Performance: Catheter Precision, Inc. reported a 135% increase in Q3 2025 revenue to $226,000 compared to Q3 2024, with a total revenue of $581,000 for the first nine months of 2025, up 114% from the previous year. The GAAP net loss for Q3 2025 was reduced by 45% to $2,251,000.

  • Product Expansion: The company is experiencing increased sales activity for its products, LockeT and VIVO, particularly in international markets following CE Mark approvals, with notable interest from countries like Germany, France, and South Africa.

  • Clinical Studies and Market Position: Catheter Precision emphasizes the importance of clinical studies, with recent publications highlighting the economic benefits of its products. CEO David Jenkins expressed confidence in the company's growth potential and the transformative impact of VIVO on treating ventricular arrhythmias.

  • Forward-Looking Statements: The company cautions that its projections and expectations regarding growth and product expansion are subject to various risks and uncertainties, including regulatory challenges, market acceptance, and financial stability.

[object Object]
Preview
2.0
08-19TipRanks
3 Penny Stocks to Keep an Eye On as of August 19, 2025

  • Penny Stocks to Watch: Soligenix, Catheter Precision, and Wellgistics Health are highlighted as penny stocks to monitor on August 19, 2025, based on their performance metrics from TipRanks’ Penny Stock Screener.

  • Soligenix (SNGX): This biopharmaceutical company saw a significant stock price increase of 78% after receiving orphan drug designation from the FDA for its treatment of Behcet’s Disease, resulting in a Dollar Volume of $914.44 million.

  • Catheter Precision (VTAK): The medical device company experienced a stock surge of over 62% following the approval of its LockeT device in the UK, leading to a Dollar Volume of $254.58 million.

  • Wellgistics Health (WGRX): The healthcare technology firm reported a nearly 21% rise in stock price due to positive news regarding its equity line termination and the launch of a blockchain payment program, achieving a Dollar Volume of $67.66 million.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Catheter Precision Inc (VTAK) stock price today?

The current price of VTAK is 2.42 USD — it has increased 1.68 % in the last trading day.

arrow icon

What is Catheter Precision Inc (VTAK)'s business?

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

arrow icon

What is the price predicton of VTAK Stock?

Wall Street analysts forecast VTAK stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VTAK is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Catheter Precision Inc (VTAK)'s revenue for the last quarter?

Catheter Precision Inc revenue for the last quarter amounts to 226.00K USD, increased 135.42 % YoY.

arrow icon

What is Catheter Precision Inc (VTAK)'s earnings per share (EPS) for the last quarter?

Catheter Precision Inc. EPS for the last quarter amounts to -1.70 USD, decreased -95.55 % YoY.

arrow icon

What changes have occurred in the market's expectations for Catheter Precision Inc (VTAK)'s fundamentals?

The market is revising No Change the revenue expectations for Catheter Precision, Inc. (VTAK) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -2.02%.
arrow icon

How many employees does Catheter Precision Inc (VTAK). have?

Catheter Precision Inc (VTAK) has 22 emplpoyees as of December 05 2025.

arrow icon

What is Catheter Precision Inc (VTAK) market cap?

Today VTAK has the market capitalization of 4.04M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free